Dow Inc. Faces Securities Fraud Allegations Following Dividend Cut

Chemical giant Dow Inc. is confronting a series of legal challenges as multiple law firms have initiated class-action lawsuits. The suits allege the company committed securities fraud by misleading investors about its true financial health and the sustainability of its dividend payout. These accusations emerged during a period already characterized by significant stock price depreciation.

Allegations of Misrepresentation and Unsustainable Dividends

The legal actions focus on a specific timeframe: late January to late July 2025. During this period, the plaintiffs claim that Dow overstated its resilience to macroeconomic headwinds and trade tariffs. Concurrently, the company is accused of downplaying severe operational challenges, including intense competitive pressure, a decline in global demand, and substantial market oversupply. A central allegation questions whether the dividend, which was still being promoted as “lucrative,” was genuinely sustainable.

The situation came to a head on July 24th, following a disastrous second-quarter earnings report. Dow announced a loss that was substantially larger than market analysts had projected and simultaneously revealed it would slash its dividend by half. Company leadership cited the need for greater financial flexibility as the primary reason for this decision. The market’s reaction was swift and severe, with the stock price plummeting more than 17% in a single day.

Should investors sell immediately? Or is it worth buying Dow Inc?

Financial Fallout and Potential Recovery Efforts

In the wake of the dividend cut, Dow’s shares have continued to struggle, losing over half of their value in the past year. This prolonged decline is attributed to high energy costs, persistently weak demand, and the industry-wide overproduction referenced in the lawsuits.

Despite the bleak outlook, some market observers point to potential signs of a turnaround. The firm has implemented aggressive measures aimed at bolstering liquidity and reducing expenditures. These initiatives include cutting capital investments, enacting ongoing cost-reduction programs, and finalizing several deals intended to collectively generate over six billion dollars in financial flexibility. The critical question remains whether these steps will be sufficient to navigate the trough of the chemical industry’s business cycle.

Investors who purchased Dow stock between the end of January and the end of July 2025 have until October 28th to apply as a lead plaintiff in the litigation. Until then, the stock is likely to remain highly sensitive to developments in the legal proceedings and to the upcoming quarterly results expected in late October.